Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer

Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer

Over 90% of prostate cancers over-express prostate specific membrane antigen (PSMA) and these tumor cells may be accurately targeted for diagnosis by 68Ga-PSMA-positron emission tomography/computed tomography (68Ga-PSMA-PET/CT) imaging. This novel molecular imaging modality appears clinically to hav...

Full description

Bibliographic Details
Main Authors: Nat P. Lenzo, Danielle Meyrick, J. Harvey Turner
Format: Article
Language:English
Published: MDPI AG 2018-02-01
Series:Diagnostics
Subjects:
theranostics
nuclear oncology
molecular imaging
68Ga-PSMA PET/CT
prostate cancer
Online Access:http://www.mdpi.com/2075-4418/8/1/16

Internet

http://www.mdpi.com/2075-4418/8/1/16

Similar Items